Protease-Activated Receptor-4, PAR-4 Antagonist, amide – 1 mg

Overview

The Protease-Activated Receptor-4 (PAR-4) antagonist, amide variant, is a highly selective peptide designed for research involving thrombin- and PAR-4 agonist-induced activation in rat platelets. If you’re studying platelet aggregation mechanisms or exploring cardiovascular research avenues, this peptide is an invaluable tool. By inhibiting thrombin and PAR-4 agonists, it allows for a clearer understanding of platelet function and signaling pathways that contribute to various physiological processes. This peptide could be a vital part of your research arsenal.

Key Features

• Selective PAR-4 antagonist
• Inhibits thrombin-induced rat platelet aggregation
• Suitable for cardiovascular research
• High purity for reliable performance
• Available in 1 mg units

Specifications

FAQ

What is the role of PAR-4 in platelet aggregation?

PAR-4 is a receptor that, when activated by thrombin, plays a crucial role in mediating platelet aggregation. Understanding how antagonists like this peptide work can help elucidate the signaling pathways involved.

How should I store the PAR-4 antagonist?

For optimal stability, store this peptide at -20°C. Avoid multiple freeze-thaw cycles, as they can compromise the integrity of the peptide.

Can I use this peptide in vivo?

This peptide is primarily designed for in vitro studies. If you’re considering in vivo applications, consult relevant literature or product experts for guidance.

The Protease-Activated Receptor-4, PAR-4 antagonist you need is just a click away. When you’re ready to advance your research, explore our complete collection of peptides that can help you dive deeper into your studies.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled